UNSPSC 51263116: Butofilolol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C17H26FNO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4AZC6Y5A8G, chemically known as 1-butanone, 1-(2-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-5-fluorophenyl)- but generally known as butofilolol, which bears US NIH Compound Identifier 68838. Butofilolol most often comes in base and maleate forms. European Medicines Agency schedules Butofilolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06029MIG.

UNSPSC 51263116 Butofilolol is a Commodity code that captures pharmaceutical products, though recent state and local solicitations under this code show minimal direct purchasing activity aligned with the nominal product scope. The two most recent opportunities posted under this code are a Seminole County, Florida IFB for naloxone and drug deactivation systems and a Texas Health and Human Services Commission RFI exploring direct-to-manufacturer prescription contracting—neither represents procurement of butofilolol itself. State and local issuing bodies soliciting pharmaceutical-adjacent work include county health departments and state health and human services agencies, though the activity volume under this specific code does not yet suggest a mature procurement category.

Seminole County, Florida posted the most concrete recent opportunity: IFB 60459723LAS, due July 26, 2023, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly delivery to the county community health building, inclusive of shipping and delivery costs, with an initial two-year term and optional one-year renewal. The Texas Health and Human Services Commission's RFI HHS0017013, posted April 3, 2026, represents exploratory activity rather than a competitive award opportunity—it sought vendor input on implementing direct-to-manufacturer prescription fulfillment outside traditional pharmacy benefit manager arrangements. Geographic activity remains limited to Florida and Texas in the recent record. The code shows sparse current activity; businesses evaluating this Commodity code should confirm that state and local procurement offices are actively tagging pharmaceutical purchases under 51263116 rather than using broader pharmaceutical family or class codes, as the limited and tangential recent solicitations suggest potential categorization misalignment rather than genuine demand for butofilolol specifically.